Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2014

Aug 22, 2014

34301_dirs_2014-08-22_c55d8e5f-e190-4ecc-b835-03f24abd43ba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2014-08-21

Reporting Person: Townsend John (Controller)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-21 Employee Stock Option - (Right to Buy) $1.40 A 15000 Acquired 2024-08-21 Common Stock (15000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1645 Direct

Footnotes

F1: The options vest over two years, with 50% cliff-vesting on August 21, 2015 and 50% vesting on August 21, 2016, subject to remaining an employee of the Company.